Beatriz Larru

Summary

Affiliation: Hospital Universitario
Country: Spain

Publications

  1. ncbi [Dengue infection in children and adolescents in Panama]
    B Larrú Martínez
    Hospital Universitario La Paz, Modesto Lafuente 59, 28003 Madrid, Spain
    An Pediatr (Barc) 64:517-22. 2006
  2. ncbi Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    BMC Infect Dis 7:55. 2007
  3. ncbi [Prevalence of resistance to antiretroviral drugs in Spain]
    B Larrú Martínez
    Hospital Universitario Gregorio Maranon, Madrid, Espana
    An Pediatr (Barc) 67:104-8. 2007
  4. ncbi Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    J Antimicrob Chemother 61:183-90. 2008
  5. ncbi [Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy]
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Enferm Infecc Microbiol Clin 26:426-9. 2008
  6. ncbi Malaria in infants below six months of age: retrospective surveillance of hospital admission records in Blantyre, Malawi
    Beatriz Larru
    Liverpool School of Tropical Medicine, University of Liverpool, Pembroke Place L35QA Liverpool, UK
    Malar J 8:310. 2009
  7. ncbi Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy
    Salvador Resino
    Laboratorio de Epidemiología Molecular de Enfermedades Infecciosas, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    Pediatr Infect Dis J 29:774-7. 2010
  8. ncbi Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection
    Ana Pilar Nso
    Servicio de Pediatría Infecciosas, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid, Spain
    Indian J Pediatr 77:397-402. 2010
  9. ncbi Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
    Salvador Resino
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    BMC Infect Dis 6:107. 2006
  10. ncbi [Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age]
    Ana Pilar Nso-Roca
    Servicio de Pediatría Infecciosas, Hospital Universitario La Paz, Madrid, Espana
    Enferm Infecc Microbiol Clin 28:278-83. 2010

Collaborators

Detail Information

Publications12

  1. ncbi [Dengue infection in children and adolescents in Panama]
    B Larrú Martínez
    Hospital Universitario La Paz, Modesto Lafuente 59, 28003 Madrid, Spain
    An Pediatr (Barc) 64:517-22. 2006
    ..Dengue is a serious emerging infectious disease and constitutes a major international health concern...
  2. ncbi Predictive factors of virological success to salvage regimens containing protease inhibitors in HIV-1 infected children
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    BMC Infect Dis 7:55. 2007
    ..The impact of HIV drug resistance mutations in salvage therapy has been widely investigated in adults. By contrast, data available of predictive value of resistance mutations in pediatric population is scarce...
  3. ncbi [Prevalence of resistance to antiretroviral drugs in Spain]
    B Larrú Martínez
    Hospital Universitario Gregorio Maranon, Madrid, Espana
    An Pediatr (Barc) 67:104-8. 2007
    ..The development of resistance to antiretroviral therapy (ART) reduces the effectiveness of these drugs in HIV-infected children...
  4. ncbi Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    J Antimicrob Chemother 61:183-90. 2008
    ..Our study aimed at evaluating the long-term use of lopinavir/ritonavir among children in a clinical setting...
  5. ncbi [Evolution of HIV and HCV coinfected children receiving long-term lopinavir/ritonavir-based antiretroviral therapy]
    Beatriz Larru
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    Enferm Infecc Microbiol Clin 26:426-9. 2008
    ..There are few studies investigating the effect of HCV coinfection on HIV-related disease among children...
  6. ncbi Malaria in infants below six months of age: retrospective surveillance of hospital admission records in Blantyre, Malawi
    Beatriz Larru
    Liverpool School of Tropical Medicine, University of Liverpool, Pembroke Place L35QA Liverpool, UK
    Malar J 8:310. 2009
    ..A number of recent reports however suggest that the burden in this young age group may be underestimated...
  7. ncbi Association between lipodystrophy and leptin in human immunodeficiency virus-1-infected children receiving lopinavir/ritonavir-based therapy
    Salvador Resino
    Laboratorio de Epidemiología Molecular de Enfermedades Infecciosas, Centro Nacional de Microbiologia, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain
    Pediatr Infect Dis J 29:774-7. 2010
    ..Increase in plasma leptin levels and leptin/adiponectin ratio was associated with LD. These adipokines may be surrogate markers of LD...
  8. ncbi Comparison of levels of antiretroviral drugs with efficacy in children with HIV infection
    Ana Pilar Nso
    Servicio de Pediatría Infecciosas, Hospital Universitario La Paz, Paseo de la Castellana 261, Madrid, Spain
    Indian J Pediatr 77:397-402. 2010
    ..To determine the prevalence of low and high antiretroviral (ARV) plasma levels and to analyze correlation between ARV concentrations and the appearance of therapeutic failure and toxicity...
  9. ncbi Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children
    Salvador Resino
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    BMC Infect Dis 6:107. 2006
    ..We studied during a 3-year follow-up period the effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children...
  10. ncbi [Plasma antiretroviral levels in children with human immunodeficiency virus infection. Influence of sex and age]
    Ana Pilar Nso-Roca
    Servicio de Pediatría Infecciosas, Hospital Universitario La Paz, Madrid, Espana
    Enferm Infecc Microbiol Clin 28:278-83. 2010
    ..An analysis was performed of plasma antiretroviral concentrations in clinical practice and their influence on therapy efficacy in HIV-infected children...
  11. ncbi Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy
    Salvador Resino
    Laboratorio de Inmuno Biología Molecular, Hospital General Universitario Gregorio Maranon, Madrid, Spain
    AIDS Res Hum Retroviruses 24:1477-84. 2008
    ..006). Overall, having a low nadir of CD4(+) hindered immune reconstitution; however, children with rapid immunologic recovery showed a higher prevalence of the lipodystrophy syndrome...
  12. ncbi HIV-infected adolescents: relationship between atazanavir plasma levels and bilirubin concentrations
    Ana P Nso Roca
    Servicio de Pediatria, Hospital Infantil La Paz, Madrid, Spain
    J Adolesc Health 48:100-2. 2011
    ..Results showed that bilirubin levels were higher among patients with higher ATV plasma concentrations (p = .018). Monitoring plasma levels of ATV could avoid toxicity in these patients...